ClinGen Expert Curation Panel for Severe Structural Anomalies and Stillbirth

ClinGen 严重结构异常和死产专家管理小组

基本信息

批准号：
10173415
负责人：
RONALD WAPNER
金额：
$ 35.61万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-09-01 至 2024-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10173415
关键词：
Amniocentesis Area Caring Childhood ClinVar Clinical Clinical Management Complex Congenital Abnormality Consensus Counseling Data Databases Developmental Biology Diagnosis Diagnostic Discipline of obstetrics Disease Edema Etiology Evaluation Fetal Diseases Genes Genetic Genetic Counseling Genomics Genotype Gestational Age Guidelines Hydrops Fetalis Image Individual Infant Infrastructure Institutes Institution International Karyotype Laboratories Literature Maternal-fetal medicine Medical Genetics Medicine Molecular Morbidity - disease rate National Institute of Child Health and Human Development Pathogenicity Perinatal Phenotype Policies Pregnancy Pregnancy Outcome Procedures Prognosis Provider Public Domains Recurrence Risk Standardization Structural defect Structure Testing Therapeutic Intervention Ultrasonography Utilization Review Validation Variant anatomic imaging causal variant clinical Diagnosis clinical care clinical imaging clinical practice clinically relevant computer science congenital anomaly developmental disease exome experience fetal genetic variant genome sequencing genomic data improved in utero interest knowledge base member mortality obstetric care prenatal reproductive outcome response stillbirth tool

项目摘要

Congenital anomalies occur in approximately 3% of all pregnancies and are a leading cause of perinatal, infant, and childhood mortality and morbidity. The majority of these anomalies are identified during pregnancy but despite the introduction of increasingly more sophisticated prenatal genomic testing such as sequencing, a specific diagnosis is hampered by our inability to accurately interpret genomic data. A leading barrier to interpretation is the lack of expert consensus regarding gene-disease association, variant pathogenicity, and actionability of findings, creating challenges for obstetric and genetic providers to offer appropriate care. Accordingly, in response to the Eunice Kennedy Shriver National institute of Child Health and Human Development's interest in the genomics of birth defects, this application is a proposal to become a participating ClinGen expert panel to evaluate the clinical relevance of genes and variants related to fetal congenital anomalies. Our proposal will develop gene disease validity and variant curation expert panels to evaluate two common and unique severe fetal disorders: non-immune fetal hydrops and unexplained stillbirth. The variant and gene curation panels are composed of experts in clinical genetics, maternal fetal medicine, molecular laboratory testing, computer science, developmental biology, genetic counseling and biocuration. Members of our expert panel come from diverse national and international institutions and have extensive experience in prenatal phenotyping and genotyping. The panel also has members who have served on other ClinGen expert panels and committees, which will facilitate our integration into the ClinGen infrastructure. Our proposal describes the details of our intended use of ClinGen policies, procedures, and tools to best determine the clinical relevance of specific genes and variants to clinical care. We are committed to sharing our data and results with others and contributing to the genetic knowledge base in the area of early developmental disease.

先天性异常发生在所有怀孕的大约3％中，是围产期，婴儿的主要原因以及童年的死亡率和发病率。这些异常大多数是在怀孕期间发现的，但尽管引入了越来越复杂的产前基因组测试，例如测序，但我们无法准确解释基因组数据，从而阻碍了特定的诊断。领先的障碍解释是缺乏有关基因疾病关联，变异性致病性和发现的可行性，为产科和遗传提供者带来挑战，以提供适当的护理。因此，回应Eunice Kennedy Shriver国家儿童健康研究所发展对先天缺陷基因组学的兴趣，该应用是成为参与的提议 Clingen专家小组评估与胎儿先天性有关的基因和变体的临床相关性异常。我们的建议将开发基因疾病有效性和变体策展专家面板，以评估两个常见且独特的严重胎儿疾病：非免疫胎儿水力和无法解释的死亡。变体和基因策划面板由临床遗传学，母体胎儿医学专家组成，分子实验室测试，计算机科学，发育生物学，遗传咨询和生物疗法。我们的专家小组成员来自多元化的国家和国际机构，并拥有广泛的具有产前表型和基因分型的经验。小组还拥有其他成员 Clingen专家小组和委员会将有助于我们整合到Clingen基础设施中。我们的建议介绍了我们预期使用固定政策，程序和工具的细节确定特定基因和变异与临床护理的临床相关性。我们致力于分享我们的与他人一起数据和结果，并为早期发展领域的遗传知识基础做出贡献疾病。